<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<title>Indications for ICD therapy</title>
<meta name="author" content="(Raja Selvaraj, JIPMER)"/>
<style type="text/css">
.underline { text-decoration: underline; }
</style>
<link rel="stylesheet" href="/js/reveal.js/css/reveal.css"/>

<link rel="stylesheet" href="/js/reveal.js/css/theme/moon.css" id="theme"/>

<link rel="stylesheet" href="local.css"/>

<!-- If the query includes 'print-pdf', include the PDF print sheet -->
<script>
    if( window.location.search.match( /print-pdf/gi ) ) {
        var link = document.createElement( 'link' );
        link.rel = 'stylesheet';
        link.type = 'text/css';
        link.href = '/js/reveal.js/css/print/pdf.css';
        document.getElementsByTagName( 'head' )[0].appendChild( link );
    }
</script>
</head>
<body>
<div class="reveal">
<div class="slides">
<section id="sec-title-slide"><h1 class="title">Indications for ICD therapy</h1><h2 class="author">Raja Selvaraj, JIPMER</h2>
</section>

<section>
<section id="slide-orgheadline1">
<h2 id="orgheadline1">Sudden death</h2>
<ul>
<li class="fragment appear">About a 1000 people attending this conference</li>
<li class="fragment appear">One of us is likely to die suddenly in the next one year (1)</li>
<li class="fragment appear">Most likely to happen outside the hospital</li>
<li class="fragment appear">Rhythm is VF if recorded within 4 minutes (2)</li>
<li class="fragment appear">We could implant ICDs in everyone to prevent that death</li>
<li class="fragment appear">Or we could learn to identify those most likely to benefit</li>

</ul>

<div class="reference">
<ol>
<li>Becker et al. Annals of Emergency Medicine 1993;22:86-91</li>
<li>Hallstrom et al. Emerg Health Services</li>

</ol>

</div>

<aside class="notes">
<p>
ICD indications is all about refining selection so that most sudden deaths are prevented with least implants. Its more about knowing when not to implant a device!
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline2">
<h2 id="orgheadline2">Sources</h2>
<ul>
<li>ACC / AHA guidelines (2008, update 2012) (1, 2)</li>
<li>ESC guidelines (2015) (3)</li>
<li>Appropriate use criteria (2013) (4)</li>
<li>Original studies</li>

</ul>

<div class="reference">
<ol>
<li>Circulation 2008;117:e350-e40</li>
<li>Circulation 2012;12</li>
<li>Eur Heart J (2015) 36 (41): 2793-2867</li>
<li>Heart Rhythm, Vol 10, No 4, April 2013:e11</li>

</ol>

</div>

</section>
</section>
<section>
<section id="slide-orgheadline3">
<h2 id="orgheadline3">Case 1</h2>
<ul>
<li>Two patients and one ICD</li>
<li>40 M, Sustained VT, old MI, LVEF 35%, NYHA I</li>
<li>40 M, MI 1 yr back, LVEF 25%, NYHA I</li>
<li>Who gets the ICD ?</li>

</ul>
<aside class="notes">
<p>
So, if you have these two patients, but for some reason can give a device to only one, whom would you choose?
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline4">
<h2 id="orgheadline4">Secondary prevention vs primary prevention</h2>
<p>
How much better is NNT ?
</p>
<ul>
<li>2 times (half)</li>
<li>3 times (third)</li>
<li>5 times</li>
<li>10 times</li>

</ul>
<aside class="notes">
<p>
So, you guessed that secondary prevention is more important than primary prevention. So what is the factor by which the NNTs are different, roughly?
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline5">
<h2 id="orgheadline5">NNT in ICD trials</h2>
<table border="2" cellspacing="0" cellpadding="6" rules="groups" frame="hsides">


<colgroup>
<col  class="org-left" />

<col  class="org-right" />

<col  class="org-right" />
</colgroup>
<thead>
<tr>
<th scope="col" class="org-left">Trial</th>
<th scope="col" class="org-right">Mortality(3yrs)</th>
<th scope="col" class="org-right">NNT(3yrs)</th>
</tr>
</thead>
<tbody>
<tr>
<td class="org-left">MADIT2</td>
<td class="org-right">31</td>
<td class="org-right">11</td>
</tr>

<tr>
<td class="org-left">SCD-HeFT (ICM)</td>
<td class="org-right">28</td>
<td class="org-right">18</td>
</tr>

<tr>
<td class="org-left">SCD-HeFT (NICM)</td>
<td class="org-right">15.8</td>
<td class="org-right">25</td>
</tr>
</tbody>
<tbody>
<tr>
<td class="org-left">MADIT</td>
<td class="org-right">42</td>
<td class="org-right">4</td>
</tr>

<tr>
<td class="org-left">MUSTT</td>
<td class="org-right">35.4</td>
<td class="org-right">5</td>
</tr>
</tbody>
<tbody>
<tr>
<td class="org-left">AVID</td>
<td class="org-right">35.9</td>
<td class="org-right">9</td>
</tr>

<tr>
<td class="org-left">CIDS</td>
<td class="org-right">27</td>
<td class="org-right">27</td>
</tr>

<tr>
<td class="org-left">CASH</td>
<td class="org-right">39</td>
<td class="org-right">13</td>
</tr>

<tr>
<td class="org-left">Metaanalysis</td>
<td class="org-right">32</td>
<td class="org-right">13</td>
</tr>
</tbody>
</table>
<div class="reference">
<p>
Betts et al. Absolute risk reduction in total mortality with implantable cardioverter defibrillators: analysis of primary and secondary prevention trial data to aid risk/benefit analysis. Europace 2013; 15 (6): 813-819
</p>

</div>
<aside class="notes">
<p>
Surprise! The NNT in primary prevention trials is almost the same as those in the secondary prevention trials. Illustrates the importance of EF over anything else. Add to it the fact that AVID patients had unstable VT/VF and poor beta blocker use in the drug group.
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline6">
<h2 id="orgheadline6">ACC guidelines</h2>
<ul>
<li>LV dysfunction / prior MI / at least 40 days post-MI / LVEF less than or equal to 30% / NYHA functional Class I. (Class I Level of Evidence: A)</li>
<li>Structural heart disease / spontaneous sustained VT /  Hemodynamically stable or unstable. - (Class I Level of Evidence: B)</li>

</ul>
<aside class="notes">
<p>
And the guidelines also favor the primary prevention patient as having more evidence towards a class I indication than the secondary prevention patient. 
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline7">
<h2 id="orgheadline7">Case 2</h2>
<ul>
<li>36 male, AWMI</li>
<li>VF on second day - defibrillated</li>
<li>LVEF 30%</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline8">
<h2 id="orgheadline8">Family apprehensive, what would you do?</h2>
<ul>
<li>ICD for secondary prevention?</li>
<li>ICD for primary prevention?</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline9">
<h2 id="orgheadline9">Primary VF - No indication for ICD</h2>
<ul>
<li>Related to reversible trigger</li>
<li>Does not affect long term outcome</li>
<li>ICD implant not indicated on this basis</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline10">
<h2 id="orgheadline10">Primary prevention?</h2>
<ul>
<li>MADIT 2 requires 40 days post MI</li>
<li>Early ICD implant not shown to be beneficial</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline11">
<h2 id="orgheadline11">ICD early post MI</h2>

<div class="figure">
<p><img src="images/dinamit_iris.jpg" alt="dinamit_iris.jpg" />
</p>
</div>

<div class="reference">
<ol>
<li>Hohnloser et al. Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction (DINAMIT) N Engl J Med 2004; 351:2481-2488</li>
<li>Steinbeck et al. Defibrillator Implantation Early after Myocardial Infarction (IRIS) N Engl J Med 2009; 361:1427-1436</li>

</ol>

</div>
<aside class="notes">
<p>
Trials of early ICD implant have consistently shown no benefit.
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline12">
<h2 id="orgheadline12">Outcome?</h2>
<ul>
<li>What is his prognosis?</li>
<li>What would you do</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline19">
<h2 id="orgheadline19">Not benign !</h2>
<ul>
<li class="fragment appear">AIVR - benign</li>
<li class="fragment appear">Primary VF - poor acute outcome</li>
<li class="fragment appear">But does not impact long term outcome</li>

</ul>


</section>
</section>
<section>
<section id="slide-orgheadline13">
<h3 id="orgheadline13">Fast MI registry - 5 year analysis of outcomes</h3>

<div class="figure">
<p><img src="images/fast_mi_front.png" alt="fast_mi_front.png" />
</p>
</div>
<aside class="notes">
<p>
French registry of patients with AMI.
Provides best longitudinal data on these patients
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline14">
<h3 id="orgheadline14">Higher early mortality</h3>

<div class="figure">
<p><img src="images/fast_mi_early_mortality.png" alt="fast_mi_early_mortality.png" />
</p>
</div>
<aside class="notes">
<p>
In hospital mortality is high
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline15">
<h3 id="orgheadline15">Long term outcome not affected</h3>

<div class="figure">
<p><img src="images/fast_mi_late_mortality.png" alt="fast_mi_late_mortality.png" />
</p>
</div>
<aside class="notes">
<p>
But long term survival not different
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline16">
<h3 id="orgheadline16">What would you do?</h3>
<ul>
<li>Revascularization</li>
<li>Beta blockers</li>
<li>Early risk stratification ?</li>

</ul>
<aside class="notes">
<p>
Revascularization and use of beta blockers are perhaps most important. May be a role for early risk stratification with holter monitoring and VT induction.
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline17">
<h3 id="orgheadline17">Appropriate use criteria for ICD implant</h3>

<div class="figure">
<p><img src="images/appropriate_early_vt.png" alt="appropriate_early_vt.png" />
</p>
</div>
<aside class="notes">
<p>
AUC suggest possible role for ICD when 
</p>
<ul>
<li>EF is low</li>
<li>Recurrent VF</li>
<li>Persistent NSVT</li>
<li>Inducible VT</li>
<li>revascularization not possible</li>

</ul>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline18">
<h3 id="orgheadline18">Wearable defibrillator</h3>

<div class="figure">
<p><img src="images/wearable_defib.jpg" alt="wearable_defib.jpg" />
</p>
</div>
<aside class="notes">
<p>
Wearable defibrillator may play a role in these situations
Provide safety net for a period until decision regarding ICD is clearer
</p>

</aside>


</section>
</section>
<section>
<section id="slide-orgheadline20">
<h2 id="orgheadline20">Case 3</h2>
<ul>
<li>75 year old male</li>
<li>Old MI</li>
<li>LVEF 30%, NYHA III</li>
<li>Creat 2.2, BUN 45</li>
<li>RBBB, QRSd 140 ms</li>
<li>Persistent atrial fibrillation</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline21">
<h2 id="orgheadline21">ICD advised elsewhere</h2>
<ul>
<li>ICD indicated as per guidelines</li>
<li>Can you deny ICD because of age?</li>
<li>What would you advise?</li>

</ul>
<aside class="notes">
<p>
By guidelines, he qualifies for an ICD. And age or other comorbidities are not contraindications unless they significantly affect his longevity.
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline22">
<h2 id="orgheadline22">HF severity and benefit</h2>

<div class="figure">
<p><img src="./images/levy_scdheft.jpg" alt="levy_scdheft.jpg" />
</p>
</div>

<div class="reference">
<p>
Levy et al. Circulation 2009;120:835-842
</p>

</div>
<aside class="notes">
<p>
As a general rule, sicker patients benefit less.
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline23">
<h2 id="orgheadline23">Other risk markers and U curve</h2>
<p>
Goldenberg - MADIT II
</p>
<ul>
<li>Age &gt; 70 yrs</li>
<li>NYHA &gt; II</li>
<li>BUN &gt; 26 mg/dl</li>
<li>QRS d &gt; 120 ms</li>
<li>Atrial fibrillation</li>

</ul>

<div class="reference">
<p>
Goldenberg et al. JACC 2008;51:288-296
</p>

</div>

<aside class="notes">
<p>
Suggested U shaped curve with most benefit in those with 1-3 risk factors
Longer follow up showed benefit in low risk group also. 
Other risk scores are FADES and Seattle Heart Failure Model
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline24">
<h2 id="orgheadline24">Other risk markers and U curve</h2>

<div class="figure">
<p><img src="./images/goldenberg.png" alt="goldenberg.png" width="70%" />
</p>
</div>

<p>
Seattle Heart Failure Model may be a better predictor
</p>
<div class="reference">
<p>
Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment. Europace (2017) 19 (1): 72-80
</p>

</div>

</section>
</section>
<section>
<section id="slide-orgheadline25">
<h2 id="orgheadline25">Case 4</h2>
<ul>
<li class="fragment appear">45 M</li>
<li class="fragment appear">Old AWMI</li>
<li class="fragment appear">LVEF 32%, NYHA II</li>
<li class="fragment appear">20% PVCs, short NSVT on holter</li>
<li class="fragment appear">What would you advise</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline26">
<h2 id="orgheadline26">Is there an indication for ICD?</h2>
<ul>
<li>LVEF &lt; 30%, NYHA I (MADIT 2)</li>
<li>LVEF &lt; 35%, NYHA II-III (SCD-HeFT)</li>
<li>EP study (MADIT / MUSTT)</li>
<li>ICD implant ?</li>

</ul>
<aside class="notes">
<p>
Not a candidate by MADIT II criteria, but yes by SCD-HeFT criteria. Might also consider under MADIT I or MUSTT criteria if inducible VT is present.
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline27">
<h2 id="orgheadline27">Ablation of PVCs</h2>

<div class="figure">
<p><img src="images/pvc_ablation1.png" alt="pvc_ablation1.png" />
</p>
</div>
<div class="reference">
<p>
Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: Safety of withholding the implant. Heart Rhythm 2015;12:2434–2442
</p>

</div>
<aside class="notes">
<p>
Even in structural heart disease, there may be a component of reversible cardiomyopathy due to PVCs. 
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline28">
<h2 id="orgheadline28">May obviate need for ICD implant!</h2>

<div class="figure">
<p><img src="images/pvc_ablation2.png" alt="pvc_ablation2.png" />
</p>
</div>

</section>
</section>
<section>
<section id="slide-orgheadline29">
<h2 id="orgheadline29">Case 5</h2>
<ul>
<li>28 year old male</li>
<li>Recurrent syncope</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline30">
<h2 id="orgheadline30">ECG</h2>

<div class="figure">
<p><img src="images/lqts2.jpg" alt="lqts2.jpg" />
</p>
</div>
<aside class="notes">
<p>
QT prolongation consistent with LQTS
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline31">
<h2 id="orgheadline31">Management?</h2>
<ul>
<li>Lifestyle modification</li>
<li>Beta blockers</li>
<li>Sympathectomy</li>
<li>ICD implantation</li>

</ul>

</section>
</section>
<section>
<section id="slide-orgheadline32">
<h2 id="orgheadline32">ICD implant in LQTS</h2>
<ul>
<li>Syncope or VT while receiving beta blockers (IIa)</li>
<li>Doing well 4 years later, on high dose beta blockers</li>

</ul>
<aside class="notes">
<p>
No need to hurry with ICD despite initial malignant presentation. Only non response to beta blockers necessitates ICD
</p>

</aside>

</section>
</section>
<section>
<section id="slide-orgheadline33">
<h2 id="orgheadline33">Conclusion - When not to implant an ICD</h2>
<ul>
<li>Expected survival with good functional status &lt; 1 yr</li>
<li>Incessant VT / VF</li>
<li>Drug refractory class IV failure, not candidate for CRT / transplant</li>
<li>VT / VF amenable to ablation</li>
<li>Arrhythmias due to completely reversible cause</li>

</ul>
</section>
</section>
</div>
</div>
<script src="/js/reveal.js/lib/js/head.min.js"></script>
<script src="/js/reveal.js/js/reveal.js"></script>

<script>
// Full list of configuration options available here:
// https://github.com/hakimel/reveal.js#configuration
Reveal.initialize({

controls: true,
progress: true,
history: true,
center: true,
slideNumber: 'c',
rollingLinks: true,
keyboard: true,
overview: true,
width: 1200,
height: 800,
margin: 0.20,
minScale: 0.50,
maxScale: 2.50,

theme: Reveal.getQueryHash().theme, // available themes are in /css/theme
transition: Reveal.getQueryHash().transition || 'none', // default/cube/page/concave/zoom/linear/fade/none
transitionSpeed: 'default',
multiplex: {
    secret: '', // null if client
    id: '', // id, obtained from socket.io server
    url: '' // Location of socket.io server
},

// Optional libraries used to extend on reveal.js
dependencies: [
 { src: '/js/reveal.js/lib/js/classList.js', condition: function() { return !document.body.classList; } },
 { src: '/js/reveal.js/plugin/markdown/marked.js', condition: function() { return !!document.querySelector( '[data-markdown]' ); } },
 { src: '/js/reveal.js/plugin/markdown/markdown.js', condition: function() { return !!document.querySelector( '[data-markdown]' ); } },
 { src: '/js/reveal.js/plugin/zoom-js/zoom.js', async: true, condition: function() { return !!document.body.classList; } },
 { src: '/js/reveal.js/plugin/notes/notes.js', async: true, condition: function() { return !!document.body.classList; } }]
});
</script>
</body>
</html>
